How many big tech companies are willing to take the risk in developing a product in the cannabis market? Is it because they know MYDX is already doing it and are cash flow positive already? How many big pharma companies are developing a medicinal marijuana vape pen that communicates to a device that can be used by doctors to help aid in prescribing remedies for their patients? Is it because they already know MYDX is doing it and is planning on releasing the product to the market by end of year? Are big pharma not taking the risk because they know they can just buy their way into MYDX and go through MYDX? How will all this affect current shareholders?
News 
Market Data 
Discover 
